Physician profile
Roger Galvez
NPI 1881685931
$4,911.37
in general payments reported to CMS, 2019-2025
19 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,188 · 2020: $492 · 2021: $695 · 2022: $1,137 · 2023: $595 · 2024: $478 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,734.61 | 2019-2025 | Gallant, Amplatzer Amulet, Aveir |
| Medtronic Vascular, INC. | $745.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $189.90 | 2020-2021 | |
| Penumbra, INC. | $160.50 | 2019 | |
| Impulse Dynamics (USA) INC. | $136.79 | 2022 | |
| Boston Scientific Corporation | $129.60 | 2019 | |
| Atricure, INC. | $126.39 | 2023 | |
| Novo Nordisk INC | $120.70 | 2020-2025 | Ozempic |
| Kestra Medical Technology Services, INC. | $111.50 | 2023-2024 | Assure Wcd |
| Biosense Webster, INC. | $95.62 | 2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $78.19 | 2021-2025 | Aurora Ev-Icd Mri Surescan |
| Amgen INC. | $50.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.43 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $41.13 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.69 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $34.81 | 2020-2021 | |
| Edwards Lifesciences Corporation | $34.08 | 2025 | |
| Cardiovascular Systems INC. | $24.64 | 2021 | |
| Amarin Pharma, INC. | $17.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Galvez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.